Gene · 140767
Papers3,844
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,844
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ultra-low level HIV p24 drives immune activation in antiretroviral therapy-treated people living with HIV. | Commun Med (Lond) | 2025 | 41331331 | PubTator, text mining | PubMed |
| Anti-cluster A and anti-p24 antibodies in people with multidrug-resistant HIV: Preliminary observations from the PRESTIGIO registry. | J Clin Virol | 2025 | 41197288 | PubTator, text mining | PubMed |
| Immunotherapy of Oncovirus-Induced Cancers: A Review on the Development and Efficacy of Targeted Vaccines. | Vaccines (Basel) | 2025 | 41012117 | PubTator, text mining | PubMed |
| Physical vitrification and nanowarming at liter-scale CPA volumes: toward organ cryopreservation. | Nat Commun | 2025 | 41006284 | PubTator, text mining | PubMed |
| High expression of Rex-orf-I and HBZ mRNAs and bronchiectasis in lung of HTLV-1A/C infected macaques. | Nat Commun | 2025 | 41006234 | PubTator, text mining | PubMed |
| Novel bioinformatics approaches to design epitope-based vaccine against HIV latency by inquiring CTL epitopes and built-in adjuvants. | Sci Rep | 2025 | 40998947 | PubTator, text mining | PubMed |
| Enhancement of lentiviral vectors gene delivery against VEGFR2 expressing cells by co-display of the binding and fusogenic moieties: a two molecules targeting approach. | Virol J | 2025 | 40993690 | PubTator, text mining | PubMed |
| Strategies to Minimize Time From HIV Acquisition to ART Initiation: The Barcelona Early-cART Program. | Open Forum Infect Dis | 2025 | 40980579 | PubTator, text mining | PubMed |
| Opsoclonus-myoclonus-ataxia Syndrome in an ART-naïve Patient With CSF/Plasma HIV-1 RNA Discordance. | Open Forum Infect Dis | 2025 | 40980571 | PubTator, text mining | PubMed |
| Targeting CD19 CAR-T With MND Promoter Enhances Tumour Killing. | J Cell Mol Med | 2025 | 40956647 | PubTator, text mining | PubMed |
| HIV-1 manipulates CD96 on CD4+ T cells to subvert antiviral immunity. | Sci Adv | 2025 | 40911682 | PubTator, text mining | PubMed |
| Structural basis for HIV-1 capsid adaption to a deficiency in IP6 packaging. | Nat Commun | 2025 | 40890096 | PubTator, text mining | PubMed |
| The Era of Gene Therapy: The Advancement of Lentiviral Vectors and Their Pseudotyping. | Viruses | 2025 | 40872751 | PubTator, text mining | PubMed |
| Inside out: TNFa-RII and sexualized drug use in acute HIV predicts persistent depressive symptoms despite antiretroviral therapy. | Brain Behav Immun Health | 2025 | 40808976 | PubTator, text mining | PubMed |
| The Multiple Platforms Effect (MPE): A quantification of how exposure to similarly biased content on multiple online platforms might impact users. | PLoS One | 2025 | 40748996 | PubTator, text mining | PubMed |
| A single mutation may contribute to accelerated evolution of SARS-CoV-2 toward Omicron. | Nat Commun | 2025 | 40730568 | PubTator, text mining | PubMed |
| Transcription-Coupled Nucleotide Excision Repair: A Faster Solution or the Only Option? | Biomolecules | 2025 | 40723898 | PubTator, text mining | PubMed |
| Classification of the Cutting Surface Topography Using a Set of Uncorrelated Parameters with High Discriminative Ability. | Materials (Basel) | 2025 | 40649619 | PubTator, text mining | PubMed |
| Vesicular Stomatitis Virus Glycoprotein- and Lentiviral RNA-Based Robust Approach for Rapid and Accurate Quantification of Viable Lentiviral Vectors. | Anal Chem | 2025 | 40600817 | PubTator, text mining | PubMed |
| PRMT3 reverses HIV-1 latency by increasing chromatin accessibility to form a TEAD4-P-TEFb-containing transcriptional hub. | Nat Commun | 2025 | 40374607 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/140767/papers?page=3